Guardian Pharmacy Services (GRDN) Insider Trading & Ownership $19.92 -0.56 (-2.73%) Closing price 03:59 PM EasternExtended Trading$19.94 +0.02 (+0.13%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Guardian Pharmacy Services (NYSE:GRDN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage63.71%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$648.54KNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$228.71M Get GRDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Guardian Pharmacy Services stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GRDN Insider Buying and Selling by Quarter Guardian Pharmacy Services Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/28/2025David K MorrisInsiderSell68,547$20.16$1,381,907.52 5/28/2025Fred BurkeInsiderSell138,705$20.16$2,796,292.80 5/28/2025John AckermanDirectorSell201,303$20.16$4,058,268.48 5/28/2025Kendall ForbesInsiderSell64,991$20.16$1,310,218.56 5/28/2025Thomas J Salentine JrDirectorSell651,454$20.16$13,133,312.64 5/28/2025William E BindleyDirectorSell651,454$20.16$13,133,312.64 5/27/2025David K MorrisInsiderSell369,212$20.16$7,443,313.92 5/27/2025Fred BurkeInsiderSell747,102$20.16$15,061,576.32 5/27/2025John AckermanDirectorSell1,084,276$20.16$21,859,004.16 5/27/2025Kendall ForbesInsiderSell350,058$20.16$7,057,169.28 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/27/2025Thomas J Salentine JrDirectorSell3,508,905$20.16$70,739,524.80 5/27/2025William E BindleyDirectorSell3,508,905$20.16$70,739,524.80 11/19/2024Steven D CoslerDirectorBuy7,000$21.22$148,540.00 9/27/2024Thomas J Salentine JrDirectorBuy35,714$14.00$499,996.00 (Data available from 1/1/2013 forward) GRDN Insider Trading Activity - Frequently Asked Questions Who is on Guardian Pharmacy Services' Insider Roster? The list of insiders at Guardian Pharmacy Services includes David K Morris, Fred Burke, John Ackerman, Kendall Forbes, Steven D Cosler, Thomas J Salentine Jr, and William E Bindley. Learn more on insiders at GRDN. What percentage of Guardian Pharmacy Services stock is owned by insiders? 63.71% of Guardian Pharmacy Services stock is owned by insiders. Learn more on GRDN's insider holdings. Which Guardian Pharmacy Services insiders have been buying company stock? The following insiders have purchased GRDN shares in the last 24 months: Steven D Cosler ($148,540.00), and Thomas J Salentine Jr ($499,996.00). How much insider buying is happening at Guardian Pharmacy Services? Insiders have purchased a total of 42,714 GRDN shares in the last 24 months for a total of $648,536.00 bought. Which Guardian Pharmacy Services insiders have been selling company stock? The following insiders have sold GRDN shares in the last 24 months: David K Morris ($8,825,221.44), Fred Burke ($17,857,869.12), John Ackerman ($25,917,272.64), Kendall Forbes ($8,367,387.84), Thomas J Salentine Jr ($83,872,837.44), and William E Bindley ($83,872,837.44). How much insider selling is happening at Guardian Pharmacy Services? Insiders have sold a total of 11,344,912 Guardian Pharmacy Services shares in the last 24 months for a total of $228,713,425.92 sold. Guardian Pharmacy Services Key ExecutivesMr. Fred P. Burke (Age 74)CEO, President & Director Compensation: $626.06k2 recent tradesMr. David K. Morris (Age 60)CFO, Executive VP & Director Compensation: $546.71k2 recent tradesMr. Kendall Forbes R.Ph. (Age 67)Executive Vice President of Sales & Operations Compensation: $543.37kMr. David MartinVice President of Technology & Senior Security OfficerMr. Douglas TownsVP & General CounselMs. Bethany Bramwell R.Ph.Senior Director of MarketingMs. Vicki CrabtreeVice President of Human ResourcesMr. Rockford AndersonPresident of Right Dose Pharmacy - IowaMr. Brian RosatiPresident of Guardian Pharmacy of DaytonaMs. Robin SmithPresident of East Tennessee Pharmacy Services More Insider Trading Tools from MarketBeat Related Companies Rush Enterprises Insider Selling Academy Sports and Outdoors Insider Selling Newegg Commerce Insider Selling Savers Value Village Insider Selling Victoria's Secret & Co. Insider Selling Camping World Insider Selling Revolve Group Insider Selling Grocery Outlet Insider Selling Arhaus Insider Selling ThredUp Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NYSE:GRDN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
